SR120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist-Reference-Cited by-同舟云学术

SR120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist

Published:1995-04-03 Issue:2 Volume:362 Page:192-196
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Serradeil-Le Gal Claudine,Valette Gérard,Rouby Pierre-Eric,Pellet Alain,Oury-Donat Florence,Brossard Gabrielle,Lespy Liliane,Marty Eléonore,Neliat Gervais,de Cointet Paul,Maffrand Jean-Pierre,Le Fur Gérard

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/0014-5793(95)00230-7/fullpdf

Reference28 articles.

1. Neuropeptide Y effector systems: perspectives for drug development

2. Effects of neuropeptide Y on the cardiovascular system

3. Neuropeptide Y as an autonomic neurotransmitter

4. CORONARY ARTERY INFUSION OF NEUROPEPTIDE Y IN PATIENTS WITH ANGINA PECTORIS

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Imaging of the Neuropeptide Y System: A Systematic Review;Molecules;2022-06-09

2. Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status;Mini-Reviews in Medicinal Chemistry;2014-10-31

3. Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH;American Journal of Physiology-Endocrinology and Metabolism;2013-03-15

4. The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer;Pharmacology & Therapeutics;2011-07

5. Endogenous Vasoactive Peptides;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15